为改善难以控制喘患者药物服药的干预措施的成本效益提供案例建模
Dacheng Huo1, Sebastian Hinde1, Harriet Smith2
1University of York Centre for Health Economics, York, England, UK.
NIHR open research
|November 21, 2025
概括
改善喘患者的药物坚持可以显著降低喘恶化和医疗保健成本. 这项研究表明,更好地遵守治疗的干预措施具有经济和健康的好处.
科学领域:
- 公共卫生 公共卫生
- 卫生经济学 卫生经济学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 喘影响着高收入国家10%以上的人口,导致大量的医疗保健利用.
- 药物不良服药是导致喘相关住院和死亡的主要原因之一.
- 这项研究确定了旨在改善喘管理中的药物坚持措施的价值.
研究的目的:
- 估计与难以控制的喘中不同程度的药物坚持相关的长期健康影响和医疗保健成本.
- 为开发和启动加强治疗坚持性的干预措施提供一个价值案例.
主要方法:
- 开发了一个具有马尔科夫结构的概率队列决策模型.
- 喘控制水平是根据全球喘倡议 (GINA) 的指导方针定义的.
- 模型参数是从已发表的文献和专家输入中得出的.
主要成果:
- 改善的坚持与更少的喘恶化和更好的患者健康结果 (寿命年,QALYs) 相关联.
- 一项干预措施将坚持从50%提高到70%,在20年内将恶化症减少了1.75%.
- 此次干预还将QALY提高了0.20,并将医疗保健成本降低了989.9英.
结论:
- 有效的干预措施来改善喘治疗的坚持,带来了巨大的经济和健康效益.
- 该研究提供了支持开发和委托这些干预措施的证据.
相关概念视频
Asthma-IV: Nursing Management
3.7K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.7K
Antiasthma Drugs: β2-Adrenoceptor Agonists
1.6K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.6K
Asthma-IV: Diagnostic and Management
3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
Inhaled Medications
702
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
702
COPD: Management Using Bronchodilators and Corticosteroids
706
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
706
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K


